The DOI matches its Crossref record; 60 of the 63 references it cites were found in a registry or an index.
Outcomes of Patients With Chronic Lung Disease and Severe Aortic Stenosis Treated With Transcatheter Versus Surgical Aortic Valve Replacement or Standard Therapy
Open accessAbstract
Objectives The study aimed to evaluate the impact of chronic lung disease (CLD) on outcomes of severe aortic stenosis patients across all treatment modalities.Background Outcomes of patients with CLD undergoing transcatheter aortic valve replacement (TAVR) have not been systematically examined.Methods All patients who underwent TAVR in the PARTNER (Placement of AoRTic TraNscathetER Valve) trial, including the continued access registry (n = 2,553; 1,108 with CLD), were evaluated according to CLD clinical severity. Additionally, outcomes of CLD patients included in the randomization arms of the PARTNER trial were compared: Cohort A patients (high-risk operable) treated by either TAVR (n = 149) or surgical aortic valve replacement (SAVR); (n = 138); and Cohort B patients (inoperable) treated by either TAVR (n = 72) or standard therapy only (n = 95).Results Among all TAVR-treated patients, at 1-year follow-up, patients with CLD had higher mortality than those without it (23.4% vs. 19.6%, p = 0.02). Baseline characteristics of CLD patients who underwent TAVR were similar to respective controls. In Cohort A, 2-year all-cause death rates were similar (TAVR 35.2% and SAVR 33.6%, p = 0.92), whereas in Cohort B, the death rate was lower after TAVR (52.0% vs. 69.6% after standard therapy only, p = 0.04). Independent predictors for mortality in CLD patients undergoing TAVR included poor mobility (6-min walk test <50 m; hazard ratio: 1.67, p = 0.0009) and oxygen-dependency (hazard ratio: 1.44, p = 0.02). Although CLD patients undergoing TAVR have worse outcomes than patients without CLD, TAVR is better in these patients than standard therapy and is similar to SAVR.Conclusions Although patients with CLD undergoing TAVR had worse outcomes than patients without CLD, TAVR performed better in these patients than standard therapy and was similar to SAVR. However, CLD patients who were either poorly mobile or oxygen-dependent had poor outcomes. (THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial; NCT00530894).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Results from some recent studies suggest that TAVR might be preferable to surgical AVR in patients with diabetes, chronic obstructive pulmonary disease, pulmonary hypertension, small aortic annulus and low-flow, low-gradient AS262–266.”
From Calcific aortic stenosis (2016) · cites this paper as [264]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008232 · Cited by 7,205
Self-citationTranscatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Smith, C. R., Leon, M. B., Mack, M. J., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103510 · Cited by 6,345
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Guidelines on the management of valvular heart disease
Vahanian, A. S., Baumgartner, H., Bax, J. J., Butchart, E., Dion, R., Filippatos, G. S., Flachskampf, F., Hall, R., Iung, B., Kasprzak, J. D., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,579
Guidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs109 · Cited by 3,559
Kappetein, A. P., Head, S. J., Généreux, P., Piazza, N., Mieghem, N. M. V., Blackstone, E., Brott, T., Cohen, D., Cutlip, D. E., van Es, G., et al. (2012) · doi:10.48350/15011 · Cited by 3,375
Self-citationTwo-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
Kodali, S., Williams, M. R., Smith, C. R., Svensson, L. G., Webb, J. G., Makkar, R., Fontana, G. P., Dewey, T. M., Thourani, V. H., Pichard, A. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200384 · Cited by 2,276
Self-citationGuidelines on the management of valvular heart disease (version 2012)
Authors Task Force Members, Vahanian, A. S., Alfieri, O., Andreotti, F., Antunes, M. J., Barón‐Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., Bonis, M. D., et al. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs455 · Cited by 2,007
Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis
Makkar, R., Fontana, G. P., Jilaihawi, H., Kapadia, S. R., Pichard, A. D., Douglas, P. S., Thourani, V. H., Babaliaros, V. C., Webb, J. G., Herrmann, H. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202277 · Cited by 1,341
Self-citation
Flagged first, then by citations
3 of the 63 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–112 of 112
Current status: Michigan's Dental Practice Act. . . review: ammendements of other states.
Stevens, R. E. (1971) · PubMed
Is transaortic valve replacement the modality of choice in patients with chronic lung disease?
Mendoza, C. E., & Celli, D. A. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15243
Chronic lung disease and quality of life following transcatheter aortic valve replacement
Imamura, T. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15386
Crestanello, J. A., Greason, K. L., Mathew, J., Eleid, M. F., Nkomo, V. T., Rihal, C. S., Bagameri, G., Holmes, D. R., Pislaru, S. V., Sandhu, G. S., et al. (2023) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezad017
Shekhar, S., Kaw, R. K., Ramu, S. K., Pampori, A., Isogai, T., Krishnaswamy, A., Puri, R., Reed, G. W., Harb, S. C., Yun, J. J., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.04.044
Self-citationYeom, R. S., Gorgone, M., Malinovic, M., Panzica, P., Maslow, A. D., Augoustides, J. G., Marchant, B. E., Fernando, R. J., Nampi, R. G., Pospishil, L., et al. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.08.005
Schwartz, G., Row, H. T., Tupa, J. M., Matter, A., Sahmoun, A. E., Haldis, T., & Dyke, C. (2024) · Cardiology and Cardiovascular Research · doi:10.11648/j.ccr.20240804.13
Böning, A., Balaban, Ü., Herrmann, E. M., Beckmann, A., Bekeredjian, R., Bleiziffer, S., Ensminger, S. M., Frerker, C., Möllmann, H., Walther, T., et al. (2025) · Interdisciplinary CardioVascular and Thoracic Surgery · doi:10.1093/icvts/ivaf189
Transcatheter Aortic Valve Replacement in Special Population Groups
Kassab, K., Modi, K., Torres, C. A., & Asif, T. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45993
Razzolini, R., Covolo, E., & Fraccaro, C. (2026) · Springer eBooks · doi:10.1007/978-3-032-04995-7_1
Observed versus Expected Mortality in Patients on Home Oxygen Undergoing Open-Heart Surgery
Gasparis, C., Agrawal, A., & Yu, P. (2026) · International Journal of Angiology · doi:10.1055/a-2844-0544
Metadata
- Authors
- Dvir, D., Waksman, R., Barbash, I. M., Kodali, S. K., Svensson, L. G., Tuzcu, E. M., Xu, K., Minha, S., Alu, M. C., Szeto, W. Y., Thourani, V. H., Makkar, R., Kapadia, S., Satler, L. F., Webb, J. G., Leon, M. B., & Pichard, A. D.
- Affiliations
- MedStar Washington Hospital Center (US)
- Columbia University Irving Medical Center (US)
- Cleveland Clinic (US)
- Hospital of the University of Pennsylvania (US)
- Emory University (US)
- Cedars-Sinai Medical Center (US)
- St. Paul's Hospital (CA)
- Corresponding author
- Waksman, Ron
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 63
- Issue
- 3
- Pages
- 269-279
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W195442482
- Cited by
- 112
- References
- 63
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 12 · 2022: 5 · 2021: 9 · 2020: 13 · 2019: 7 · 2018: 7 · 2017: 12 · 2016: 17 · 2015: 15 · 2014: 4
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Boston Scientific
- Medtronic
- Volcano
- Eli Lilly
- Daiichi Sankyo
- AstraZeneca
- Abbott Vascular
- Edwards Lifesciences and Medtronic CardioVascular
- Edwards Lifesciences and Sorin Medical
- Edwards Lifesciences and St. Jude Medical
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- chronic lung disease, severe aortic stenosis, transcatheter aortic valve implantation, surgical aortic valve replacement, mortality, PARTNER trial, inoperable patients, 6-minute walk test, oxygen dependence, mortality risk factors
- MeSH terms
- Aged, 80 and over, Aortic Valve Stenosis, Cause of Death, Chronic Disease, Female, Follow-Up Studies, Cardiac Catheterization, Heart Valve Prosthesis, Humans, Lung Diseases, Male, Severity of Illness Index, United States, Survival Rate, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
